These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14505486)

  • 1. Postprandial lipaemia in familial combined hyperlipidaemia.
    Castro Cabezas M
    Biochem Soc Trans; 2003 Oct; 31(Pt 5):1090-3. PubMed ID: 14505486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia.
    Verseyden C; Meijssen S; Castro Cabezas M
    J Lipid Res; 2002 Feb; 43(2):274-80. PubMed ID: 11861669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial inflammation and endothelial dysfuction.
    Alipour A; Elte JW; van Zaanen HC; Rietveld AP; Cabezas MC
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):466-9. PubMed ID: 17511629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease.
    Karpe F
    Diabet Med; 1997 Aug; 14 Suppl 3():S60-6. PubMed ID: 9272616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia.
    Evans K; Burdge GC; Wootton SA; Collins JM; Clark ML; Tan GD; Karpe F; Frayn KN
    Atherosclerosis; 2008 Mar; 197(1):164-70. PubMed ID: 17466309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and free fatty acids: double trouble.
    Castro Cabezas M; Halkes CJ; Erkelens DW
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):134-42. PubMed ID: 11434190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.
    Meijssen S; van Dijk H; Verseyden C; Erkelens DW; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):811-6. PubMed ID: 12006395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.
    Meijssen S; Cabezas MC; Twickler TB; Jansen H; Erkelens DW
    J Lipid Res; 2000 Jul; 41(7):1096-102. PubMed ID: 10884291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids.
    Brouwers MC; Bilderbeek-Beckers MA; Georgieva AM; van der Kallen CJ; van Greevenbroek MM; de Bruin TW
    Clin Sci (Lond); 2007 Jan; 112(2):123-30. PubMed ID: 16958621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disturbances of lipoprotein metabolism in metabolic syndrome].
    Czyzewska M; Wolska A; Cwiklińska A; Kortas-Stempak B; Wróblewska M
    Postepy Hig Med Dosw (Online); 2010 Jan; 64():1-10. PubMed ID: 20093718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
    Kwiterovich PO
    Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia.
    Verseyden C; Meijssen S; van Dijk H; Jansen H; Castro Cabezas M
    J Lipid Res; 2003 Nov; 44(11):2100-8. PubMed ID: 12923226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.
    Nakajima K; Tanaka A
    Clin Chim Acta; 2018 Mar; 478():200-215. PubMed ID: 29307667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.
    Cruz-Bautista I; Mehta R; Cabiedes J; García-Ulloa C; Guillen-Pineda LE; Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
    Clin Chim Acta; 2015 Jan; 438():160-5. PubMed ID: 25172037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
    Taghizadeh E; Esfehani RJ; Sahebkar A; Parizadeh SM; Rostami D; Mirinezhad M; Poursheikhani A; Mobarhan MG; Pasdar A
    IUBMB Life; 2019 Sep; 71(9):1221-1229. PubMed ID: 31271707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 as a key regulator of lipid and lipoprotein metabolism in fasting and postprandial states.
    Farr S; Taher J; Adeli K
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):126-36. PubMed ID: 24801723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
    de Roos B; Caslake MJ; Milliner K; Benson GM; Suckling KE; Packard CJ
    Atherosclerosis; 2005 Jul; 181(1):63-8. PubMed ID: 15939055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.